Uveitis Patient Selection Key for Adalimumab Treatment
Adalimumab for the treatment of noninfectious uveitis has advantages over no treatment or conventional treatment with steroid therapy.
Adalimumab Approved for Uveitis
In this story, we revisit the clinical trials that led to the approval of adalimumab for uveitis.
Adalimumab Improves Uveitis, Studies Show
Adalimumab improves function and quality of life for patients with uveitis, shows a study presented at 2015 ACR/ARHP.
The Eyes May Be Windows on the Spine
A new tool could help ophthalmologists who see uveitis collaborate in the early diagnosis of spondyloarthritis.
Options in Tough-To-Treat Uveitis
Reports in a pediatric ophthalmology journal reveal risk factors and best treatments for refractory/recurrent uveitis in JIA.
Babesiosis in a Patient With Corticosteroid-Resistant Uveitis
The tumor necrosis factor α antagonist infliximab has been used for treating patients with uveitis resistant to corticosteroids.
By clicking Accept, you agree to become a member of the UBM Medica Community.